​​​

© 2015 by Cure ATRT Now

Email us:

info@cureatrt.org

 

Write us:

1 Colonial Drive,

Merrimac, MA 01860

 

Call us:

877-481-3300

 

  • Facebook - White Circle
  • Twitter - White Circle
  • Facebook - White Circle
  • Twitter - White Circle
  • Tumblr - White Circle

Social:

Cure ATRT

 

Avalanna

 

  • HOME

  • ABOUT US

  • GET INVOLVED

  • WE CAN HELP

  • BLOG

  • DONATE

  • More

    Share

    info@cureatrt.org

    Research

    ​

    • Improved 6- year overall survival in AT/RT –results of the registry study Rhabdoid 2007 (Bartelheim, Nemes, et al)

    • ATRTs are composed of three epigenetic subgroups... suggest potential therapeutic targets (Johann et al)

    • Roberts Lab Update, April 10, 2015

    • Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis (Torchia et al)

    • Pitfalls in the diagnosis of atypical teratoid rhabdoid (AT/RT): experiences from the European rhabdoid tumor registry (Hasselblatt, Kordes, et al)

    • Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors (Ho, Shih, Liang et al)

    • Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. (Slavc, Chocholous et al)

    • Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2 (Knutson, Warholic, et al) 

    • Atypical Teratoid Rhabdoid Tumors (Venneti, Kalpana et al)

    • Molecular Pathways: SWI/SNF (BAF) Complexes Are Frequently Mutated in Cancer—Mechanisms and Potential Therapeutic Insights (Wang, Haswell & Roberts)

    • Pediatric Brain Cancer Research (Dana Farber Cancer Institute)

    • Atypical Teratoid Rhabdoid Tumours (AT/RT): A French Retrospective Study

    • Atypical Teratoid Rhabdoid Tumors (Sredni & Lulla)

    • Rhabdoid tumors: integrating biological insights with clinical success (Bourdeaut, Chi, Fruwald)

    • Atypical Teratoid Rhabdoid Tumors: Current Therapy and Future Directions (Ginn & Gajjar)

    • Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis (Buscariollo, Park et al)

    • Atypical teratoid rhabdoid tumor: long-term survival after chemoradiotherapy (Verma & Johnson)

    • Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells (Venkataraman, Alimova et al)

    • Vulnerabilities of Mutant SWI/SNF Complexes in Cancer (Helming, Wang & Roberts)

     

     
    Hospitals
     

    • Boston Childrens Hospital

    • Dana Farber Cancer Institute

    • St Judes Childrens Research Hospital

    • iSTAR AT/RT Laborator, Childrens Hospital Chicago